Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Geographic and demographic features of neuroendocrine tumors in the United States of America: A population-based study.

Gosain R, Ball S, Rana N, Groman A, Gage-Bouchard E, Dasari A, Mukherjee S.

Cancer. 2019 Nov 12. doi: 10.1002/cncr.32607. [Epub ahead of print]

PMID:
31714595
2.

One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial.

Singh AK, Gomez-Suescun JA, Stephans KL, Bogart JA, Hermann GM, Tian L, Groman A, Videtic GM.

Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):752-759. doi: 10.1016/j.ijrobp.2019.08.019. Epub 2019 Aug 22.

PMID:
31445956
3.

Cutaneous Leiomyosarcoma: A SEER Database Analysis.

Sandhu N, Sauvageau AP, Groman A, Bogner PN.

Dermatol Surg. 2019 Jul 11. doi: 10.1097/DSS.0000000000002029. [Epub ahead of print]

PMID:
31306276
4.

Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer.

Miller JA, Groman A, Yendamuri S, Hennon M.

J Surg Res. 2019 Apr;236:259-265. doi: 10.1016/j.jss.2018.11.052. Epub 2018 Dec 24.

PMID:
30694764
5.

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

Chen GL, Hahn T, Wilding GE, Groman A, Hutson A, Zhang Y, Khan U, Liu H, Ross M, Bambach B, Higman M, Neppalli V, Sait S, Block AW, Wallace PK, Singh AK, McCarthy PL.

Biol Blood Marrow Transplant. 2019 Apr;25(4):689-698. doi: 10.1016/j.bbmt.2018.09.042. Epub 2018 Oct 6.

PMID:
30300731
6.

Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database.

Hennon MW, Kumar A, Devisetty H, D'Amico T, Demmy TL, Groman A, Yendamuri S.

J Thorac Oncol. 2019 Jan;14(1):107-114. doi: 10.1016/j.jtho.2018.09.024. Epub 2018 Oct 5.

PMID:
30292851
7.

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.

Merzianu M, Groman A, Hutson A, Cotta C, Brynes RK, Orazi A, Reddy V, Teruya-Feldstein J, Amre R, Balasubramanian M, Brandao G, Cherian S, Courville E, Czuchlewski D, Fan G, Grier D, Hoehn D, Inamdar KV, Juskevicius R, Kaur P, Lazarchick J, Lewis MR, Miles RR, Myers JB, Nasr MR, Qureishi HN, Olteanu H, Robu VG, Salaru G, Vajpayee N, Vos J, Zhang L, Zhang S, Aye L, Brega E, Coad JE, Grantham J, Ivelja S, McKenna R, Sultan K, Wilding G, Hutchison R, Peterson L, Cheney RT.

Am J Clin Pathol. 2018 Oct 1;150(5):393-405. doi: 10.1093/ajcp/aqy066.

8.

Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.

Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R.

PLoS One. 2018 Jun 11;13(6):e0198809. doi: 10.1371/journal.pone.0198809. eCollection 2018.

9.

Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.

Yendamuri S, Dhillon SS, Groman A, Dy G, Dexter E, Picone A, Nwogu C, Demmy T, Hennon M.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):394-402. doi: 10.1016/j.jtcvs.2018.03.113. Epub 2018 Apr 4.

PMID:
29709364
10.

Combined surgery and radiation improves survival of tonsil squamous cell cancers.

Singh AK, Mimikos C, Groman A, Dibaj S, Platek AJ, Cohan DM, Hicks WL Jr, Gupta V, Arshad H, Kuriakose MA, Warren GW, Platek ME.

Oncotarget. 2017 Aug 10;8(68):112442-112450. doi: 10.18632/oncotarget.20122. eCollection 2017 Dec 22.

11.

Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow.

Sharma UC, Sonkawade SD, Baird A, Chen M, Xu S, Sexton S, Singh AK, Groman A, Turowski SG, Spernyak JA, Mahajan SD, Pokharel S.

Cardiooncology. 2018;4. pii: 8. doi: 10.1186/s40959-018-0034-1. Epub 2018 Dec 18.

12.

Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.

Yendamuri S, Groman A, Miller A, Demmy T, Hennon M, Dexter E, Picone A, Nwogu C, Dy GK.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):656-663. doi: 10.1093/ejcts/ezx406.

13.

Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.

Kukar M, Gabriel E, May R, Cho E, Lichtenthal M, Groman A, Skitzki J, Francescutti V, Kane JM 3rd.

Am Surg. 2017 Nov 1;83(11):1256-1262.

PMID:
29183528
14.

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).

Pili R, Quinn DI, Hammers HJ, Monk P, George S, Dorff TB, Olencki T, Shen L, Orillion A, Lamonica D, Fragomeni RS, Szabo Z, Hutson A, Groman A, Perkins SM, Piekarz R, Carducci MA.

Clin Cancer Res. 2017 Dec 1;23(23):7199-7208. doi: 10.1158/1078-0432.CCR-17-1178. Epub 2017 Sep 22.

15.

Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma.

Wentink MQ, Verheul HMW, Pal SK, George S, Voortman J, Danchaivijitr P, Adelaiye R, Poslinski D, Groman A, Hutson A, Pili R.

Clin Genitourin Cancer. 2017 Jul 14. pii: S1558-7673(17)30201-X. doi: 10.1016/j.clgc.2017.07.004. [Epub ahead of print]

PMID:
28781191
16.

Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers.

Jackson-Rose J, Del Monte J, Groman A, Dial LS, Atwell L, Graham J, O'Neil Semler R, O'Sullivan M, Truini-Pittman L, Cunningham TA, Roman-Fischetti L, Costantinou E, Rimkus C, Banavage AJ, Dietz B, Colussi CJ, Catania K, Wasko M, Schreffler KA, West C, Siefert ML, Rice RD.

Clin J Oncol Nurs. 2017 Aug 1;21(4):438-445. doi: 10.1188/17.CJON.438-445.

PMID:
28738039
17.

Clinical characteristics of adenosquamous esophageal carcinoma.

Yendamuri S, Malhotra U, Hennon M, Miller A, Groman A, Halloon A, Reid ME.

J Gastrointest Oncol. 2017 Feb;8(1):89-95. doi: 10.21037/jgo.2016.12.03.

18.

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer.

Iyer RV, Pokuri VK, Groman A, Ma WW, Malhotra U, Iancu DM, Grande C, Saab TB.

Am J Clin Oncol. 2018 Jul;41(7):649-655. doi: 10.1097/COC.0000000000000347.

PMID:
27849649
19.

Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011.

Platek ME, Jayaprakash V, Gupta V, Cohan DM, Hicks WL Jr, Winslow TB, Platek AJ, Groman A, Dibaj S, Arshad H, Kuriakose MA, Warren GW, Singh AK.

Laryngoscope. 2017 May;127(5):1087-1092. doi: 10.1002/lary.26369. Epub 2016 Nov 3.

PMID:
27808409
20.

Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker.

Ait-Oudhia S, Mager DE, Pokuri V, Tomaszewski G, Groman A, Zagst P, Fetterly G, Iyer R.

CPT Pharmacometrics Syst Pharmacol. 2016 Jun;5(6):297-304. doi: 10.1002/psp4.12084. Epub 2016 Jun 8.

21.

Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial.

Pokuri VK, Tomaszewski GM, Ait-Oudhia S, Groman A, Khushalani NI, Lugade AA, Thanavala Y, Ashton EA, Grande C, Fetterly GJ, Iyer R.

Am J Clin Oncol. 2018 Apr;41(4):332-338. doi: 10.1097/COC.0000000000000286.

PMID:
27014931
22.

Progression of gingival squamous cell carcinoma from early to late stage after invasive dental procedure.

Hinchy NV, Jayaprakash V, Rigual N, Reid M, Frustino JL, Rossitto R, Groman A, Sullivan MA.

Gen Dent. 2016 Mar-Apr;64(2):38-43.

PMID:
26943087
23.

Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.

Mix M, Singh AK, Tills M, Dibaj S, Groman A, Jaggernauth W, Rustum Y, Jameson MB.

World J Clin Oncol. 2015 Oct 10;6(5):166-73. doi: 10.5306/wjco.v6.i5.166.

24.

A Formal Palliative Care Service Improves the Quality of Care in Patients with Stage IV Cancer and Bowel Obstruction.

Gabriel E, Kukar M, Groman A, Alvarez-Perez A, Schneider J, Francescutti V.

Am J Hosp Palliat Care. 2017 Feb;34(1):20-25. doi: 10.1177/1049909115603960. Epub 2016 Jul 10.

PMID:
26377552
25.
26.

New Polymorphic Forms of Pemetrexed Diacid and Their Use for the Preparation of Pharmaceutically Pure Amorphous and Hemipentahydrate Forms of Pemetrexed Disodium.

Michalak O, Łaszcz M, Jatczak K, Witkowska A, Bujak I, Groman A, Cybulski M.

Molecules. 2015 Jul 30;20(8):13814-29. doi: 10.3390/molecules200813814.

27.

Development and validation of the GC method for the quantitative determination of semi-volatile solvents in the pharmaceutical substance bosentan.

Stolarczyk EU, Groman A, Łuniewski W.

Acta Pol Pharm. 2014 Nov-Dec;71(6):1107-13. No abstract available.

28.

Determination of organic volatile impurities in nepafenac by GC method.

Mucha M, Groman A, Zagrodzka J, Cybulski M.

Acta Pol Pharm. 2014 Nov-Dec;71(6):1013-22.

29.

Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis.

Kukar M, Kapil A, Papenfuss W, Groman A, Grobmyer SR, Hochwald SN.

J Surg Oncol. 2015 May;111(6):696-701. doi: 10.1002/jso.23873. Epub 2015 Jan 5.

PMID:
25560251
30.

Hospice utilization and end-of-life care in metastatic breast cancer patients at a comprehensive cancer center.

O'Connor TL, Ngamphaiboon N, Groman A, Luczkiewicz DL, Kuszczak SM, Grant PC, Kerr CW.

J Palliat Med. 2015 Jan;18(1):50-5. doi: 10.1089/jpm.2014.0238.

PMID:
25353618
31.

Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.

Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A, Matsuzaki J, Tsuji T, Groman A, Gnjatic S, Spagnoli G, Lele S, Odunsi K.

PLoS One. 2014 Aug 7;9(8):e104099. doi: 10.1371/journal.pone.0104099. eCollection 2014.

32.

The use of modified four-dimensional computed tomography in patients with primary hyperparathyroidism: an argument for the abandonment of routine sestamibi single-positron emission computed tomography (SPECT).

Kukar M, Platz TA, Schaffner TJ, Elmarzouky R, Groman A, Kumar S, Abdelhalim A, Cance WG.

Ann Surg Oncol. 2015 Jan;22(1):139-45. doi: 10.1245/s10434-014-3940-y. Epub 2014 Jul 30.

PMID:
25074663
33.

Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

Dhillon SS, Groman A, Meagher A, Demmy T, Warren GW, Yendamuri S.

J Cancer Sci Ther. 2014 Jul;6(7):217-222. Epub 2014 Jun 30.

34.

In vivo toxicity, metabolism and pharmacokinetic properties of FAK inhibitor 14 or Y15 (1, 2, 4, 5-benzenetetramine tetrahydrochloride).

Golubovskaya V, Curtin L, Groman A, Sexton S, Cance WG.

Arch Toxicol. 2015 Jul;89(7):1095-101. doi: 10.1007/s00204-014-1290-y. Epub 2014 Jun 12.

PMID:
24915938
35.

Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.

Jarkowski A 3rd, Hare R, Loud P, Skitzki JJ, Kane JM 3rd, May KS, Zeitouni NC, Nestico J, Vona KL, Groman A, Khushalani NI.

Am J Clin Oncol. 2016 Dec;39(6):545-548.

PMID:
24879468
36.

Adjuvant treatment for uterine leiomyosarcoma.

Akers SN, Groman A, Odunsi K, Lele S, Frederick PJ.

Eur J Gynaecol Oncol. 2013;34(5):409-14.

PMID:
24475573
37.

Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer.

Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI.

Surg Endosc. 2014 Apr;28(4):1090-5.

PMID:
24232046
38.

Small cell carcinoma of the esophagus: a SEER database analysis.

Kukar M, Groman A, Malhotra U, Warren GW, Bogner P, Nwogu CE, Demmy TL, Yendamuri S.

Ann Surg Oncol. 2013 Dec;20(13):4239-44. doi: 10.1245/s10434-013-3167-3. Epub 2013 Aug 14.

PMID:
23943025
39.

Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study.

Akers SN, Riebandt G, Miller A, Groman A, Odunsi K, Lele S.

Eur J Gynaecol Oncol. 2013;34(2):113-9.

40.

Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma.

Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS.

J Gastrointest Oncol. 2013 Jun;4(2):137-43. doi: 10.3978/j.issn.2078-6891.2013.007.

41.

Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.

Yendamuri S, Huang M, Malhotra U, Warren GW, Bogner PN, Nwogu CE, Groman A, Demmy TL.

Cancer. 2013 Sep 1;119(17):3156-61. doi: 10.1002/cncr.28099. Epub 2013 May 29.

42.

Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.

Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, Groman A, Tian L, Singh PK, Sucheston LE, Johnson CS, Trump DL, Fakih MG.

Horm Cancer. 2013 Aug;4(4):242-50. doi: 10.1007/s12672-013-0139-9. Epub 2013 Feb 28.

43.

Time-trends in survival in young women with breast cancer in a SEER population-based study.

Ademuyiwa FO, Groman A, Hong CC, Miller A, Kumar S, Levine E, Erwin D, Ambrosone C.

Breast Cancer Res Treat. 2013 Feb;138(1):241-8. doi: 10.1007/s10549-013-2425-1. Epub 2013 Feb 1.

PMID:
23371505
44.

A phase II study of high-dose cetuximab plus irinotecan in colorectal cancer patients with KRAS wild-type tumors who progressed after standard dose of cetuximab plus irinotecan.

Fora AA, McMahon JA, Wilding G, Groman A, Ma WW, Romano KS, Fakih MG.

Oncology. 2013;84(4):210-3. doi: 10.1159/000346328. Epub 2013 Jan 17.

PMID:
23328486
45.

Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer.

Kiran G, Kesterson JP, Ozerkan K, Kanis M, Groman A, Lele S.

Eur J Gynaecol Oncol. 2013;34(6):522-6.

PMID:
24601043
46.

Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis.

Yendamuri S, Sharma R, Demmy M, Groman A, Hennon M, Dexter E, Nwogu C, Miller A, Demmy T.

J Surg Res. 2013 Jul;183(1):27-32. doi: 10.1016/j.jss.2012.11.052. Epub 2012 Dec 20.

PMID:
23260233
47.

Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.

Kulkarni S, Augoff K, Rivera L, McCue B, Khoury T, Groman A, Zhang L, Tian L, Sossey-Alaoui K.

PLoS One. 2012;7(8):e42895. doi: 10.1371/journal.pone.0042895. Epub 2012 Aug 27.

48.

Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis.

Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, Demmy TL, Groman A, Reid M.

Surgery. 2012 Sep;152(3):397-402. doi: 10.1016/j.surg.2012.05.007. Epub 2012 Jun 26.

PMID:
22739072
49.

Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer.

Nwogu CE, Groman A, Fahey D, Yendamuri S, Dexter E, Demmy TL, Miller A, Reid M.

Ann Thorac Surg. 2012 May;93(5):1614-9; discussion 1619-20. doi: 10.1016/j.athoracsur.2012.01.065. Epub 2012 Mar 20.

50.

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer.

Fakih MG, Groman A, McMahon J, Wilding G, Muindi JR.

Cancer Chemother Pharmacol. 2012 Mar;69(3):743-51. doi: 10.1007/s00280-011-1762-1. Epub 2011 Oct 22.

PMID:
22020318

Supplemental Content

Loading ...
Support Center